全文获取类型
收费全文 | 36415篇 |
免费 | 1877篇 |
国内免费 | 732篇 |
专业分类
耳鼻咽喉 | 331篇 |
儿科学 | 229篇 |
妇产科学 | 2050篇 |
基础医学 | 918篇 |
口腔科学 | 273篇 |
临床医学 | 4339篇 |
内科学 | 3052篇 |
皮肤病学 | 201篇 |
神经病学 | 568篇 |
特种医学 | 1044篇 |
外国民族医学 | 7篇 |
外科学 | 7888篇 |
综合类 | 8109篇 |
预防医学 | 2542篇 |
眼科学 | 563篇 |
药学 | 3009篇 |
93篇 | |
中国医学 | 788篇 |
肿瘤学 | 3020篇 |
出版年
2024年 | 10篇 |
2023年 | 429篇 |
2022年 | 785篇 |
2021年 | 1096篇 |
2020年 | 1121篇 |
2019年 | 747篇 |
2018年 | 718篇 |
2017年 | 1026篇 |
2016年 | 1262篇 |
2015年 | 1265篇 |
2014年 | 2932篇 |
2013年 | 2554篇 |
2012年 | 2622篇 |
2011年 | 2735篇 |
2010年 | 2100篇 |
2009年 | 2018篇 |
2008年 | 1983篇 |
2007年 | 2123篇 |
2006年 | 1899篇 |
2005年 | 1687篇 |
2004年 | 1389篇 |
2003年 | 1070篇 |
2002年 | 904篇 |
2001年 | 784篇 |
2000年 | 630篇 |
1999年 | 449篇 |
1998年 | 385篇 |
1997年 | 361篇 |
1996年 | 265篇 |
1995年 | 271篇 |
1994年 | 230篇 |
1993年 | 163篇 |
1992年 | 135篇 |
1991年 | 108篇 |
1990年 | 89篇 |
1989年 | 74篇 |
1988年 | 78篇 |
1987年 | 79篇 |
1986年 | 66篇 |
1985年 | 65篇 |
1984年 | 66篇 |
1983年 | 29篇 |
1982年 | 50篇 |
1981年 | 39篇 |
1980年 | 31篇 |
1979年 | 30篇 |
1978年 | 22篇 |
1977年 | 16篇 |
1976年 | 9篇 |
1975年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
目的探讨核心肌群稳定性训练联合生物反馈在早期宫颈癌根治术后患者盆底康复中的应用效果。方法采用便利抽样法,于2018年8月—2021年7月选取在南京大学医学院附属鼓楼医院接受妇科手术治疗的宫颈癌患者130例为研究对象。按照随机数字表法将患者分为试验组和对照组,各65例。对照组采用常规康复护理措施,试验组采取核心肌群稳定性训练联合生物反馈的康复护理措施,比较两组患者盆底电生理功能、盆底功能障碍患者生活质量量表(PFDI-20)、盆底功能障碍问卷(PFIQ-7)评分。结果干预后试验组患者各项盆底肌电值均高于对照组,Ⅰ、Ⅱ类肌纤维疲劳值均低于对照组,差异有统计学意义(P<0.01)。干预后试验组患者PFDI-20、PFIQ-7评分均低于对照组,差异有统计学意义(P<0.01)。结论采取核心肌群稳定性训练联合生物反馈对早期宫颈癌根治术后盆底康复的疗效较好,值得临床推广使用。 相似文献
2.
宫颈癌是我国女性最常见的生殖系统恶性肿瘤,根治性手术是早期宫颈癌的主要治疗方式,但手术范围大,技术难度高,术后可能出现的并发症多。吲哚菁绿(indocyanine green,ICG)荧光成像技术在外科手术中的应用已十分广泛,并有越来越多的研究表明其在宫颈癌根治术中也展现出巨大的应用前景,在示踪前哨淋巴结、识别盆腔神经、评估子宫血流灌注和保护输尿管等方面发挥着积极作用。这不仅提高了术中肿瘤切除的准确性,还能实现重要解剖结构的可视化,进一步减少术后并发症、改善预后,使患者获益。但目前ICG荧光成像技术在宫颈癌手术治疗中的应用尚处于初步阶段,仍需进一步扩大样本去验证其安全性及有效性。 相似文献
3.
4.
《European journal of surgical oncology》2022,48(3):482-491
ObjectiveTo systematically evaluate the clinicopathological and prognostic value of extra-hepatic bile duct resection (EHBDR) in the surgical management of patients with gallbladder carcinoma (GBC), especially in non-jaundiced patients.MethodsPubMed, EMBASE and the Cochrane Library were searched up to March 1st 2021 for comparative studies between bile duct resected and non-resected groups. RevMan5.3 and Stata 13.0 software were used for the statistical analyses.ResultsEHBDR did not correlate with a better overall survival (OS) (P = 0.17) or disease-free survival (P = 0.27). No survival benefit was also observed in patients with T2N1 (P = 0.4), T3N0 (P = 0.14) disease and node-positive patients (P = 0.75), rather, EHBDR was even harmful for patients with T2N0 (P = 0.01) and node-negative disease (P = 0.02). Significantly higher incidences of recurrent disease (P = 0.0007), postoperative complications (P < 0.00001) and positive margins (P = 0.02) were detected in the bile duct-resected group. The duration of postoperative hospital stay between the two groups was comparable (P = 0.58). Selection bias was also detected in our analysis that a significantly higher proportion of advanced lesions with T3-4 or III-IV disease was observed in the bile duct-resected group (P < 0.00001). EHBDR only contributed to a greater lymph yield (P = 0.01).ConclusionEHBDR has no survival advantage for patients with GBC, especially for those with non-jaundiced disease. Considering the unfairness of comparing OS between jaundiced patients receiving EHBDR with non-jaundiced patients without EHBDR, we could only conclude that routine EHBDR in non-jaundiced patients is not recommended and future well-designed studies with more specific subgroup analyses are required for further validation. 相似文献
5.
6.
Introduction and objectivesOptimal treatment of hepatocellular carcinoma (HCC) involving portal vein tumor thrombus (PVTT) remains controversial.Materials and methodsA total of 627 HCC patients with PVTT after initial treatment with one of the following at Affiliated Tumor Hospital of Guangxi Medical University: liver resection (LR, n = 225), transarterial chemoembolization (TACE, n = 298) or sorafenib (n = 104) were recruited and randomly divided into the training cohort (n = 314) and internal validation cohort (n = 313). Survival analysis were repeated after stratifying patients by Cheng PVTT type.ResultsResection led to significantly higher OS than the other two treatments among patients with type I or II PVTT. TACE worked significantly better than the other two treatments for patients with type III. All three treatments were associated with similar OS among patients with type IV. These findings were supported by the internal validation cohort.ConclusionsOur results suggest that the optimal treatment for HCC involving PVTT depends on the type of PVTT. LR may be more appropriate for type I or II PVTT; TACE, for type III Sorafenib may be more appropriate than invasive treatments for patients with type IV PVTT. 相似文献
7.
《Digestive and liver disease》2022,54(11):1486-1493
BackgroundCold snare polypectomy (CSP) is a promising technique for the removal of sessile serrated polyps (SSPs) ≥ 10 mm. However, the efficacy and safety of this technique remain undetermined.AimsWe aimed to comprehensively evaluate the efficacy and safety of CSP for SSPs ≥ 10 mm.MethodsPubMed, EMBASE, Web of Science and Cochrane Library were searched up to January 2021.ResultsA total of 10 studies consisting of 1727 SSPs (range, 10–40 mm) from 1021 patients were included. The overall rates of technical success, adverse events (AEs) and residual SSPs were 100%, 0.7% and 2.9%, respectively. Subgroup analysis showed that the rates of technical success and AEs were comparable between CSP and cold endoscopic mucosal resection (EMR) (99.9% vs. 100% and 1.3% vs. 0.5%, respectively), between the proximal and distal colon (100% vs. 99.9% and 0.3% vs. 0, respectively), and between polyps of 10–19 mm and ≥20 mm (99.8% vs. 100% and 0.9% vs. 0, respectively). However, subgroup analysis showed that the rate of residual SSPs was slightly lower in CSP compared with cold EMR (1.3% vs. 3.9%), as well as in polyps of 10–19 mm compared with those ≥20 mm (3.1% vs. 4.7%).ConclusionCSP was an effective and safe technique for removing SSPs ≥ 10 mm. 相似文献
8.
9.
《Journal of vascular and interventional radiology : JVIR》2022,33(4):359-367.e8
PurposeTo review and to compare indirectly the outcomes of minimally invasive therapies for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.Materials and MethodsA literature search via Medline and Cochrane Central databases was completed for randomized control studies published between January 2000 to April 2020 for the following therapies: Rezum, Urolift, Aquablation, and prostatic artery embolization (PAE). Data on the following variables were included: International prostate symptom score (IPSS), maximum urinary flow rate, quality of life, and postvoid residual (PVR). Standard mean differences between treatments were compared through a meta-analysis using transurethral resection of the prostate (TURP) to assess differences in treatment effect.ResultsThere was no significant difference in outcomes between therapies for IPSS at the 3, 6, and 12-month follow ups. Although outcomes for Rezum were only available out to 3 months, there were no consistently significant differences in outcomes when comparing Aquablation versus PAE versus Rezum. TURP PVR was significantly better than Urolift at 3, 6, and 12 months. No significant differences in minor or major adverse events were noted.ConclusionAlthough significant differences in outcomes were limited, Aquablation and PAE were the most durable at 12 months. PAE has been well studied on multiple randomized control trials with minimal adverse events while Aquablation has limited high quality data and has been associated with bleeding-related complications. 相似文献
10.
The Effect of 5-Fluorouracil on the Adhesion Process in Patients Operated on for Colorectal Cancer 下载免费PDF全文
Serik ZhakipbekovMuratbek OsombaevSerik Irimbetov 《Asian Pacific journal of cancer prevention》2022,23(3):995-1003
Objective: The aim of this study was to improve the direct results of reconstructive surgery in patients operated on for complicated forms of colorectal cancer, by using 5-fluorouracil in the postoperative period. Methods: The study involved 126 patients (they were divided into 2 groups) with colorectal cancer, who underwent reconstructive surgery. They underwent a standard clinical examination and a mandatory examination program. Results: The use of 5-fluorouracil in adjuvant treatment in patients with colorectal cancer significantly reduces the number of subjective clinical manifestations (positional tests) in the main group – 17%, and in the control group – 54.3%, as well as objective clinical manifestations (instrumental research methods) in Group I – 13%, and Group II – 89.5%, respectively. The study shows that in re-operated patients with colorectal cancer who received 5-fluorouracil, abdominal adhesions are characterized by a low content of collagen and fibroblasts, low vascularization and a high content of polymerized fibrin strands. It was also found that re-operated patients with colorectal cancer who did not receive 5-fluorouracil, abdominal adhesions are characterized by a high collagen content, a large number of fibroblasts, and severe angiogenesis. Conclusion: It was found that the prolonged administration of 5-fluorouracil statistically significantly reduces the risk of adhesions, thereby showing the effectiveness of preventing adhesive disease of the abdominal organs. It was shown that the prolonged administration of 5-fluorouracil significantly reduces the number of subjective and objective signs of adhesive disease of the abdominal organs, as well as significantly decreases intraoperative and postoperative complications, the duration of the operation, and the amount of blood loss. In the postoperative period, it reduces the length of hospital stay and improves the quality of life of patients. 相似文献